Column Group IV, LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 40,327 shares at $5.00 ($202K) on 2022-11-22, disclosed to the SEC on 2022-11-23.
Open-market purchase of $202k NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 35,997 | $180K | 89.3% |
| 2 | $5.00 | 4,330 | $22K | 10.7% |
| Total | $5.00 avg | 40,327 | $202K | 100% |
| Filing → |
| NGM | BUY | 2022-05-17 | $842K | — | Filing → |